Androxal

Legal status in the UK

Androxal (enclomifene) is not licensed in the UK and is not commercially available here.

Basic Androxal information

• INN (international nonproprietary name): Enclomifene, alternative spelling enclomiphene.
• Brand names: Androxal® (development name), EnCyzix (former name); not marketed in the United Kingdom.
• ATC code: No ATC code assigned.
• Forms and strengths: oral tablets studied in 12.5 mg and 25 mg strengths.
• Manufacturers in the United Kingdom: Not specified.
• Registration status in the United Kingdom: No UK approval, no MHRA licence, and no legitimate pharmacy distribution.
• OTC / Rx classification: Prescription-only in investigational settings; not available over the counter.

Clinical effectiveness: what UK patients and clinicians should know

Can it help when testosterone is low?

There is no NHS-established treatment pathway for Androxal because it is not licensed in the UK.

Any effect seen in studies relates to supporting the body’s own testosterone production rather than replacing testosterone directly, which is different from exogenous TRT.

For UK patients, the outcomes that matter are often practical ones: energy, libido, fertility preservation, mood, and whether treatment is easy to stick with.

Those outcomes have not been shown well enough for routine prescribing, and medical societies do not recommend enclomifene for standard care.

• Trial setting: investigated in male secondary hypogonadism only.
• Routine care: no approved NHS outcomes data.
• Patient expectation: some people want a “testosterone boost”, but specialist assessment and blood tests come first.

Indications and why Androxal is not an MHRA-approved option

Is this something a GP can simply prescribe, or something you might see advertised online before you ever get NHS advice?

The answer is straightforward: there is no MHRA approval, no OTC status, and no legitimate UK prescription route.

The investigational use was male secondary hypogonadism, with possible fertility-related interest because it may support endogenous testosterone rather than suppress sperm production in the way some exogenous treatments can.

That is very different from an approved medicine available through normal UK supply chains.

It also matters that some sites call it a research chemical, which puts it outside standard pharmacy regulation.

Off-label

Using a licensed medicine for a purpose not stated in its UK licence.

Unlicensed medicine

A product without UK marketing authorisation.

Research chemical

A substance sold for laboratory or investigational use, not as a regulated medicine.

• Androxal: not commercially available.
• EnCyzix: not active in current use.
• Prescription status: no marketing authorisation.

Composition, brand names and product identity in the United Kingdom context

Is enclomifene the same thing as clomifene?

Enclomifene is the active (E)-isomer associated with clomifene chemistry, and the alternative spelling enclomiphene is also seen in the literature.

Androxal® was a development brand, not a marketed UK medicine, and EnCyzix was only a tentative former name.

Packaging was expected as oral tablets, usually as enclomifene citrate, but development stopped before any commercial packs reached pharmacy shelves.

Contraindications and special precautions for UK readers

Who should definitely avoid it, and who needs extra caution even in a trial-style setting?

The clearest contraindications from the evidence are hypersensitivity, hormone-dependent tumours, and pregnancy.

Relative cautions include severe hepatic or renal impairment, a history of thrombosis or embolism, and uncontrolled endocrine disorders.

Common side effects reported with enclomifene include headache, nausea, blurred vision, hot flushes, and mood changes.

Those symptoms matter in day-to-day life because blurred vision or mood swings can affect driving, shift work, and concentration.

There is no studied dosing safety for children or older adults, so there is no established routine use in those groups.

Questions about alcohol or self-medication come up often in UK pharmacies, but for this compound the evidence is too thin to make reassuring claims.

• Do not use: if you have hypersensitivity to enclomifene or clomifene compounds.
• Do not use: if you are pregnant or have a hormone-dependent tumour.
• Use caution: if you have liver, kidney, clotting, or complex endocrine problems.

Dosage guidelines from clinical trials, not NHS prescribing

How much was studied, and what should a patient do if a dose is missed?

All dosage information comes from clinical studies only, not from NHS or MHRA-approved prescribing guidance.

The commonly studied regimen was 12.5 mg to 25 mg taken orally once daily for male secondary hypogonadism.

Studies explored daily use for up to 6 months, while long-term safety and efficacy remain unknown.

Children were not studied, elderly use is not established, and hepatic or renal impairment was avoided.

If a dose is missed, the practical advice is simple: take it when remembered, unless the next one is due soon.

If too much is taken, there is no specific reversal medicine, so supportive care is the approach described in the data.

Interactions: medicines, alcohol and everyday UK use

What about the everyday things people actually ask about, like alcohol, supplements, and gym products?

Interaction evidence is limited because the medicine is not marketed, so much of the caution is based on pharmacology rather than robust real-world data.

Likely concerns would be with other hormone-active treatments and medicines that can affect mood or vision, but it would be unwise to overstretch what is known.

In the UK, adverse reaction reporting through the MHRA Yellow Card system still matters, although the data for unlicensed products will be sparse.

The biggest practical issue is unregulated online supply, where purity, dose, and even the actual contents may be uncertain.

• Alcohol: no good evidence base for safety.
• Supplements and gym products: caution if they affect hormones or mood.
• Overdose: no established antidote.

Comparable medicines and United Kingdom preferences

If enclomifene is not an option, what do UK clinicians usually consider instead?

The closest comparator is clomifene citrate (Clomid), because it has a similar mechanism.

Tamoxifen is another SERM that may be discussed in some settings, while testosterone replacement therapy directly supplies exogenous testosterone rather than stimulating the body to make more of its own.

UK clinicians generally prefer medicines with clearer safety data, formal prescribing routes, and monitoring frameworks.

That preference is not just bureaucracy; it is how side effects, fertility issues, and treatment failure are kept under control.

• Fertility: a major reason some men ask about SERMs rather than TRT.
• Convenience: TRT is often simpler to obtain through formal routes.
• Monitoring: established medicines come with clearer follow-up expectations.

Frequently asked questions about Androxal

Is Androxal available on the NHS? No, it is not licensed in the UK and has no NHS prescribing route.

Is it the same as clomifene? No, but it is closely related; enclomifene is the active (E)-isomer of clomifene.

Proper use, counselling and NHS support pathways

When someone comes in worried about low testosterone, the safest advice is to start with diagnosis, not with a purchase.

Book a GP review, ask about blood tests, and use NHS patient portals or the NHS App to check results and next steps.

If any future specialist use were ever considered, it would need close oversight, but at present there is no standard prescription pathway.

Keep any product in original packaging, at room temperature between 15 and 30°C, and protect it from moisture.

If a side effect is suspected, report it through UK systems and speak to a pharmacist first so the symptoms can be put in context.

1. Confirm the diagnosis with a GP and blood tests.
2. Check current medicines, supplements, and any hormone treatments.
3. Avoid unlicensed online supply and any grey-market product.
4. Store properly if a product has already been obtained, and do not exceed studied doses.
5. Seek urgent help for severe symptoms, especially visual changes or signs of thrombosis.

Delivery across the United Kingdom

Important note: in our online pharmacy, Androxal is available without a prescription, with discreet delivery to the United Kingdom in 9–21 days.

That access statement does not change the clinical reality, though, because the medicine remains unlicensed and the evidence base is still limited to investigational use.